NVAX Latest Press Releases

-- November 5, 2026 --

Novavax Reports Third Quarter 2026 Financial Results and Operational Highlights PRNewswire 8:00 AM

-- October 29, 2026 --

Novavax Earns $125 Million Milestone as Sanofi Launches Phase 3 Influenza-COVID-19 Combination Vaccine Trial in Europe PRNewswire 9:38 AM

Novavax to Report Third Quarter 2026 Financial Results on November 5, 2026 PRNewswire 8:00 AM

-- September 2, 2026 --

Novavax to Participate in September Investor Conferences PRNewswire 5:00 PM

-- August 28, 2026 --

Novavax's Partnership Strategy Continues to Deliver with XFG-adapted Nuvaxovid Approvals in the U.S., EU and Japan for 2026-2027 Vaccination Season PRNewswire 8:30 AM

-- August 6, 2026 --

Novavax Reports Second Quarter 2026 Financial Results and Operational Highlights PRNewswire 8:00 AM

-- July 30, 2026 --

Novavax to Report Second Quarter 2026 Financial Results on August 6, 2026 PRNewswire 7:00 AM

Market Data Delayed 15 Minutes